Figure 2.
Kaplan–Meier curves of treatment persistence of studied biologics. Each curve presents the cumulative persistence rate according to drug exposure duration (in years) for adalimumab (ADA), infliximab (IFX), and vedolizumab (VDZ).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.